VIVIMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations & Disclosure Requirements), 2015, further to our letter dated 30.09.2023, we hereby bring to your notice that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 14th Day of November, 2023 at Hyderabad inter alia to consider and approve un-audited Financial Results (Standalone & Consolidated) of the company for the quarter and half year ended 30th September, 2023. Further, we would like to inform that pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the company has intimated its 'Designated Persons including Directors' regarding the closure of trading window from 01.10.2023 to till 48 hours after the declaration of un-audited Financial Results (Standalone & Consolidated) of the company for the quarter and half year ended 30th September, 2023.